Scientists have come one step closer to finding toxin antidotes that will make hospital-acquired infections and enterotoxic E.

Highlighting the significance of this study, IMCB Principal Investigator, Dr Frederic Bard said, "Through this genome-wide screen, our understanding of how toxins interact with human cells at the molecular level has expanded tremendously."
By identifying the specific host genes required for these toxins to attack the cell's protein 'factories', this study effectively singled out the attractive therapeutic targets from the entire human genome for developing antidotes that could potentially be effective against any toxins that share the same mode of action.
Source-ANI
MEDINDIA




Email





